CN
75-15-0
Applied Filters:
Keyword:'75-15-0'
Showing 1-30 of 1910 results for "75-15-0" within Technical Documents
PureFlex™ Plus Single-use Process Container Film
observed in the samples extracted at room temperature.1
0
15
30
45
60
75
1 7 30 60 90 120
0
15
30
PLA & PLGA Polymer Portfolio for Peptide & Small Molecule Formulation
COOH 0.25-0.35 15-40
EXPANSORB® DLG 65-6A 5.43122 PLGA 65/35 COOH 0.50-0.65 45-85
EXPANSORB® DLG 75-2A 5.43124 PLGA 75/25 COOH 0.08-0.21 5-20
EXPANSORB® DLG 75-5A 5.43125 PLGA 75/25 COOH 0.38-
Millistak+ activated carbon for mAb downstream purification
4.
0%
0 250 500 750 1000 1250
75%
100%
50%
25%
MAb Loading (mg/mL)
pH 5, 3.5 mS
pH 7, 3.5 mS
pH 5, 15 mS
pH 7, 15 mS
Pe
rc
en
t
White Paper: Accelerating Cell Line and Process Development
at
io
n
(
g
/L
)
Days
Clone F Titer
0 3 6 9 12 15 242118
• Advanced • Adv 75:25 4Feed • Adv 50:50 4Feed
Seed Train Intensification Using High Cell Density Cryopreservation and Specially-designed Expansion Medium
0 75 61 2 3 4
V
C
D
[
10
6
V
C
/m
L]
days
CHO K1
Expansion in Expansion Medium
Expansion in ExCEll® Advanced HD Perfusion Medium
0
25
20
Raloxifene Hydrochloride (USP)
(min) Solution A (%) Solution B (%)
0.00 75 25
9.00 75 25
40.25 50 50
42.25 75 25
49.00 75 25
-20
0
20
40
60
80
Poster: Virus clearance using Eshmuno HCX
NaCl
75 mM NaCl
0 mM NaCl
300 mM NaCl
150 mM NaCl
75 mM NaCl
0 mM NaCl
300 mM NaCl
150 mM NaCl
75 mM NaCl
0 mM
Viscosity-Reducing Excipients for Protein Formulation
excipient.
0
60
40
20
80
100
Co
nt
ro
l
12
5
m
M
Ar
g
15
0
m
M
Om
12
5
m
M
Ph
e
15
0
m
M
Product Information Sheet-11417991001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet-11417959001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
The Vmax Nomograph
0.0075
0.
10
0.
05
0
0.
02
5
0.
01
0
0.
00
50
0.
00
15
0.
00
07
5
0.
00
05
0.
00
03
5
0.
00
02
5
Product Information Sheet - 11417983001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet - 11082035001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417975001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417967001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
In Vitro Evaluation of Novel Silica Materials to Enhance the Dissolution Rate of Fenofibrate and Itraconazole
26 week)
65 70 75 80 85 90 95
Temperature (°C)
Fenofibrate (crystalline)
Drug-loaded silica (initial)
Drug-loaded silica (26 week)
0
20
40
60
80
100
0 30 60 90
A comparative study of hydrophobic and hydrophilic lubricants for optimal combination of galenical and dissolution properties
itraconazole.
Dissolution performace of itraconazole
1000 mL SGFsp pH 1.2; 75 rpm
Time [min]
5
1
2
3
4
0
0 15 30 45 60 75 90 105 120
Pure itraconazole Tablets with
NovAseptic Mixer: High Shear In-Line Mixer Users guide, Technical Description, Installation, Operating Instructions, Maintenance
rotation (A) speed and rotor (E) speed.
15(36)
D
oc
um
en
t M
L-
0
75
The Effective Use of Protein Kinase Inhibitors
35
2
(1
0
µM
)
PD
9
80
59
(P
-2
15
) (
50
µ
M
)
SB
-2
03
58
0
(S
8
30
7)
(1
0
µM
Esomeprazole Magnesium (USP) - Delayed Release Capsules Purospher®STAR RP-18 endcapped - Dissolution (Assay)
Omeprazole 15.6 1.00 3.2 1.2
0
5
10
15
20
25
30
0 5 10 15 20 25 30 35 40 45
Retention Time (minutes)
Blank
0
10
Single Pass Tangential Flow Filtration (SPTFF)
120%
18-20 g/L 1-sections
18-20 g/L 2-sections
18-20 g/L 3-sections
75 g/L 1-sections
75 g/L 2-sections
75 g/L 3-sections
C
on
ve
rs
io
n
Feed lpm/m2 total
N
W
P
(l
m
h/
User Guide TurboMix Bis Tris Gel Casting Kit
)
mPAGE® Combs
0 .75 mm, 10 wells 5 C75M10W
0 .75 mm, 15 wells 5 C75M15W
1 .0 mm, 10 wells 5 C1M10W
1 .0 mm, 15 wells 5 C1M15W
1 .5 mm, 10 wells
Enhancing the Solubility of Active Pharmaceutical Ingredients Using Hot Melt Extrusion and Polyvinyl Alcohol
formulation 30% drug load in 900 mL SGFsp;
paddle speed at 75 rpm, total runtime 120 minutes; n = 3.
0
Time [min]
30
20
10
0
15 30 45 60 75 90 105 120
The Effective Use of Protein Kinase Inhibitors
35
2
(1
0
µM
)
PD
9
80
59
(P
-2
15
) (
50
µ
M
)
SB
-2
03
58
0
(S
8
30
7)
(1
0
µM
PureFlex™ and PureFlex™ Plus White Paper
acetone 67-64-1 10.0
Acetaldehyde (TIC) 75-07-0 51
water yes
acetone 67-64-1 75
tert-butyl alcohol 75-65-0 64
2-butanone 78-93-3 29
acetaldehyde (TIC) 75-07-0 188
Butanal (TIC) 123-72-8 58
Pentanal
Mobius®Single-Use Technology Supporting ADC Processing
30
20
10
0
2 2.5 3 3.5 4 4.5 5 5.5 6 7 8 9 10 12 14 16 18 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
Steam-in-Place Sterilization of Filtration Trains containing Milligard®PES Prefilters
sterilization.
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
0 605 10 15 20 25 30 35 40 45 50 55 65 70 75 80 85 90 95
T
em
Application Note- Mobius®Power MIX: Scalability in Mixing
liquid-liquid mixing time (at 75% volume) confirms the scalability relationship.
Figure 7. Scalability in mixing 1.5M NaCl in Mobius® Power MIX from 100 L to 2000 L.
0
5
10
15
20
100
User Guide (IFU) -110079
substances in mg/l
Acetate 1000 Mg2+ 1000 EDTA 1000
Ag+ 75 Mn2+ 1000
Al3+ 1000 Na+ 1000
Ascorbate 10 NH4+ 1000
BO33- 1000 Ni2+ 1000
Br- 75 NO2-
Filtration of viscous / particle-laden samples using the Samplicity®Filtration System
2.1
B.
0
10
5
25
20
15
30
35
40
Fi
lt
ra
ti
on
t
im
e
(s
ec
.)
Conditioner Shampoo Liquid dish
detergent
Water
Page 1 of 64